Based on these results Protelos is in Europe for the treatment of postmenopausal osteoporosis.

Based on these results Protelos is in Europe for the treatment of postmenopausal osteoporosis , licensed to reduce the risk of vertebral and hip fractures. It is now in 16 countries, including Germany, Britain, Spain and Italy, both patients and physicians both to help in the fight against postmenopausal osteoporosis available.

References: 1 Marie PJ, Ammann P, Boivin G, mechanisms of action and therapeutic potential of strontium in bone. Calcif Tissue Int. 2001 69:121-129. Meunier PJ, Seeman E.

Protelos received an EU license in the treatment of postmenopausal osteoporosis, by 21 the risk of vertebral and hip fractures in the September 2004 to reduce.To have also noticed when they gave a drug used to block IDO expression and collected the immune. – ‘Our hypothesis this situation, that the bad guys in which case were actually cells from the host, ordinary cells was in one sense, cancer tumor,’says Dr. David Munn, pediatric hemato – oncologist and lead author of the trial on the 15th July issue of the Journal of Clinical Investigation published. The potential to use of IDO mechanism to is immune response immune response in many other sectors, suppress protecting such as that transplanted organs by rejection and the immune system battle HIV helps examines.

This conference covers symposium with focus on statistic models of materials buckyballs of Materials about scales, computational materials style and soft condensed matter and biology the reaction and reaction of material extreme conditions the nuclear reactor environmental. FSUs Francis Eppes Professor Chemistry and Biochemistry Harold Kroto, the won a Nobel Prize in 1996 for his co – detection ‘buckyballs.